Invacare Corporation (IVC) Upgraded at Zacks Investment Research

Invacare Corporation (NYSE:IVC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “Invacare Corporation is the world’s leading manufacturer and distributor of non-acute health care products based upon its distribution channels, the breadth of its product line and sales. The company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment including the home health care, retail and extended care markets. The company’s products are sold through its world-wide distribution network byits sales force, telemarketing employees and various organizations of independent manufacturer’s representatives. “

A number of other equities research analysts have also weighed in on IVC. BidaskClub lowered Invacare Corporation from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. ValuEngine upgraded Invacare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Finally, KeyCorp restated an “overweight” rating and set a $17.00 price objective on shares of Invacare Corporation in a research note on Tuesday, September 26th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. Invacare Corporation has a consensus rating of “Hold” and a consensus target price of $14.50.

Shares of Invacare Corporation (NYSE:IVC) opened at 14.25 on Wednesday. The company’s 50-day moving average price is $14.74 and its 200 day moving average price is $13.70. Invacare Corporation has a 1-year low of $8.00 and a 1-year high of $16.65. The stock’s market cap is $468.40 million.

Invacare Corporation (NYSE:IVC) last issued its quarterly earnings data on Monday, August 7th. The health services provider reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.21). Invacare Corporation had a negative net margin of 6.42% and a negative return on equity of 12.79%. The business had revenue of $233.50 million for the quarter, compared to analyst estimates of $243.03 million. During the same quarter last year, the business earned ($0.33) EPS. Invacare Corporation’s revenue for the quarter was down 15.1% compared to the same quarter last year. Equities analysts forecast that Invacare Corporation will post ($1.87) EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Invacare Corporation (IVC) Upgraded at Zacks Investment Research” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://ledgergazette.com/2017/10/11/invacare-corporation-ivc-upgraded-at-zacks-investment-research.html.

In other Invacare Corporation news, SVP Dean J. Childers sold 6,249 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $15.15, for a total transaction of $94,672.35. Following the completion of the sale, the senior vice president now owns 44,875 shares in the company, valued at approximately $679,856.25. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 3.20% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Koch Industries Inc. acquired a new position in shares of Invacare Corporation in the 2nd quarter worth approximately $255,000. 1st Global Advisors Inc. acquired a new position in shares of Invacare Corporation in the 2nd quarter worth approximately $138,000. Schneider Capital Management Corp grew its position in shares of Invacare Corporation by 126.4% in the 2nd quarter. Schneider Capital Management Corp now owns 288,770 shares of the health services provider’s stock worth $3,812,000 after acquiring an additional 161,245 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Invacare Corporation by 0.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 25,974 shares of the health services provider’s stock worth $343,000 after acquiring an additional 119 shares in the last quarter. Finally, State Street Corp grew its position in shares of Invacare Corporation by 8.3% in the 2nd quarter. State Street Corp now owns 837,448 shares of the health services provider’s stock worth $11,054,000 after acquiring an addi

According to Zacks, “Invacare Corporation is the world’s leading manufacturer and distributor of non-acute health care products based upon its distribution channels, the breadth of its product line and sales. The company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment including the home health care, retail and extended care markets. The company’s products are sold through its world-wide distribution network byits sales force, telemarketing employees and various organizations of independent manufacturer’s representatives. “

A number of other equities research analysts have also weighed in on IVC. BidaskClub lowered Invacare Corporation from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. ValuEngine upgraded Invacare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Finally, KeyCorp restated an “overweight” rating and set a $17.00 price objective on shares of Invacare Corporation in a research note on Tuesday, September 26th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. Invacare Corporation has a consensus rating of “Hold” and a consensus target price of $14.50.

Shares of Invacare Corporation (NYSE:IVC) opened at 14.25 on Wednesday. The company’s 50-day moving average price is $14.74 and its 200 day moving average price is $13.70. Invacare Corporation has a 1-year low of $8.00 and a 1-year high of $16.65. The stock’s market cap is $468.40 million.

Invacare Corporation (NYSE:IVC) last issued its quarterly earnings data on Monday, August 7th. The health services provider reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.21). Invacare Corporation had a negative net margin of 6.42% and a negative return on equity of 12.79%. The business had revenue of $233.50 million for the quarter, compared to analyst estimates of $243.03 million. During the same quarter last year, the business earned ($0.33) EPS. Invacare Corporation’s revenue for the quarter was down 15.1% compared to the same quarter last year. Equities analysts forecast that Invacare Corporation will post ($1.87) EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Invacare Corporation (IVC) Upgraded at Zacks Investment Research” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://ledgergazette.com/2017/10/11/invacare-corporation-ivc-upgraded-at-zacks-investment-research.html.

In other Invacare Corporation news, SVP Dean J. Childers sold 6,249 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $15.15, for a total transaction of $94,672.35. Following the completion of the sale, the senior vice president now owns 44,875 shares in the company, valued at approximately $679,856.25. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 3.20% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Koch Industries Inc. acquired a new position in shares of Invacare Corporation in the 2nd quarter worth approximately $255,000. 1st Global Advisors Inc. acquired a new position in shares of Invacare Corporation in the 2nd quarter worth approximately $138,000. Schneider Capital Management Corp grew its position in shares of Invacare Corporation by 126.4% in the 2nd quarter. Schneider Capital Management Corp now owns 288,770 shares of the health services provider’s stock worth $3,812,000 after acquiring an additional 161,245 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Invacare Corporation by 0.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 25,974 shares of the health services provider’s stock worth $343,000 after acquiring an additional 119 shares in the last quarter. Finally, State Street Corp grew its position in shares of Invacare Corporation by 8.3% in the 2nd quarter. State Street Corp now owns 837,448 shares of the health services provider’s stock worth $11,054,000 after acquiring an additional 63,917 shares in the last quarter.

About Invacare Corporation

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Receive News & Ratings for Invacare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply